Search hospitals > Pennsylvania > Pittsburgh
Children's Hospital of Pittsburgh of UPMC
Claim this profilePittsburgh, Pennsylvania 15224
Global Leader in Brain Tumor
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Uterine Tumors
Conducts research for Relapse
Conducts research for Lymphoma
907 reported clinical trials
83 medical researchers
Summary
Children's Hospital of Pittsburgh of UPMC is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Brain Tumor, T-Lymphoblastic Leukemia/Lymphoma, Uterine Tumors, Relapse, Lymphoma and other specialties. Children's Hospital of Pittsburgh of UPMC is involved with conducting 907 clinical trials across 1,092 conditions. There are 83 research doctors associated with this hospital, such as Jean M. Tersak, Andrew Bukowinski, Adam Olson, and James Felker, MD.Area of expertise
1Brain Tumor
Global LeaderBRAF positive
Stage IV
BRAF negative
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderStage II
Philadelphia chromosome positive
NTRK1 positive
Top PIs
Jean M. TersakChildren's Hospital of Pittsburgh of UPMC7 years of reported clinical research
Expert in Cancer
Expert in Uterine Tumors
43 reported clinical trials
99 drugs studied
Andrew BukowinskiChildren's Hospital of Pittsburgh of UPMC9 years of reported clinical research
Studies Relapse
Studies Uterine Tumors
24 reported clinical trials
38 drugs studied
Adam OlsonUPMC-Shadyside Hospital1 year of reported clinical research
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
17 reported clinical trials
55 drugs studied
James Felker, MDChildren's Hospital of Pittsburgh of UPMC5 years of reported clinical research
Studies Cerebral Gliomas
Studies Brain Tumor
17 reported clinical trials
29 drugs studied
Clinical Trials running at Children's Hospital of Pittsburgh of UPMC
Brain Tumor
Acute Lymphoblastic Leukemia
Cancer
Uterine Tumors
Acute Myeloid Leukemia
Wilms Tumor
T-Lymphoblastic Leukemia/Lymphoma
Acute Leukemia
Relapse
Lymphoma
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Lower Radiotherapy Dose
for Brain Tumors
This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria
Tiragolumab + Atezolizumab
for Solid Tumors
This trial studies how well tiragolumab and atezolizumab work in children and adults with difficult-to-treat tumors missing specific genes. These treatments help the immune system attack cancer and stop it from growing. Atezolizumab is an antibody that has been used with other treatments for various cancers.
Recruiting1 award Phase 1 & 214 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Children's Hospital of Pittsburgh of UPMC?
Children's Hospital of Pittsburgh of UPMC is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Brain Tumor, T-Lymphoblastic Leukemia/Lymphoma, Uterine Tumors, Relapse, Lymphoma and other specialties. Children's Hospital of Pittsburgh of UPMC is involved with conducting 907 clinical trials across 1,092 conditions. There are 83 research doctors associated with this hospital, such as Jean M. Tersak, Andrew Bukowinski, Adam Olson, and James Felker, MD.
Where is Children's Hospital of Pittsburgh of UPMC located?
The Children's Hospital of Pittsburgh of UPMC is located at 4401 Penn Ave, Pittsburgh, PA 15224, United States.
Who should I call to ask about financial aid or insurance network?
**Children's Hospital of Pittsburgh of UPMC Financial Assistance:**
- Contact the Business Office at 412-692-7600, available from 8 a.m. to 4 p.m., Monday through Friday.
**UPMC Western Maryland Insurance Hotline:**
- For insurance-related inquiries, call 240-964-8111.
What insurance does Children's Hospital of Pittsburgh of UPMC accept?
The Children's Hospital of Pittsburgh of UPMC accepts a wide range of health insurance plans. This includes commercial insurance plans such as Aetna, Capital Blue Cross, Cigna Health, and United HealthCare, among others. Government insurance plans accepted include Military insurances like VA and Tricare, Medicare plans such as Aetna Medicare Advantage and Highmark Freedom Blue, and Medicaid plans like Aetna Better Health and UPMC for You.
What awards or recognition has Children's Hospital of Pittsburgh of UPMC received?
UPMC Children's Hospital of Pittsburgh supports research through various grants, including:
- Pilot grants: $50,000 per year for two years.
- Trainee grants: $50,000 per year for two years.
- The Ghazi Lab has received research grants from the American Federation for Aging Research and the University of Pittsburgh.
- The Children's Neuroscience Institute offers annual Interdisciplinary Neuroscience Awards (INA) of up to $50,000, favoring projects that involve multi-omic platforms, induced pluripotent stem cell technology, bioinformatics, and molecular imaging approaches.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.